ImageneBio Inc
58 hedge funds and large institutions have $142M invested in ImageneBio Inc in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 3 closing their positions.
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
178% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 9
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
12% more funds holding
Funds holding: 52 → 58 (+6)
1.02% more ownership
Funds ownership: 73.62% → 74.63% (+1%)
31% less capital invested
Capital invested by funds: $205M → $142M (-$63.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Verition Fund Management
Greenwich,
Connecticut
|
+$3.31M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.29M |
| 3 |
VVA
Vida Ventures Advisors
Boston,
Massachusetts
|
+$1.13M |
| 4 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$911K |
| 5 |
BlackRock
New York
|
+$897K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.07M |
| 2 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$79.5K |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$35K |
| 4 |
Citigroup
New York
|
-$31.7K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$10.5K |
IMA Hedge Fund Activity: Q3 2023 in Review
58 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q3 2023, worth a combined $142M — down 31% from $205M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new IMA positions and 3 closed out — a net gain of 6 holders — while 25 added to existing stakes and 9 trimmed.
The largest buyer was Verition Fund Management, adding an estimated $3.31M. The largest seller was Fidelity Investments, cutting an estimated $3.07M.
- 58 institutional investors held ImageneBio Inc (IMA) as of Q3 2023, up from 52 in Q2 2023.
- Funds reported $142M of ImageneBio Inc stock for Q3 2023, down 31% quarter-over-quarter.
- 9 funds opened new ImageneBio Inc positions in Q3 2023 and 3 closed out, a net change of +6 holders.
- The largest ImageneBio Inc buyer in Q3 2023 was Verition Fund Management, an estimated $3.31M added.
- The largest ImageneBio Inc seller in Q3 2023 was Fidelity Investments, an estimated $3.07M sold.
Based on aggregated 13F filings for Q3 2023.